US Broker Ratings

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 22.96% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the rapidly evolving field of precision oncology. By offering cutting-edge blood and tissue tests,..

Grifols, S.A. (GRFS) Investor Outlook: Capturing a 19.61% Potential Upside Amid Growth and Innovation

Grifols, S.A. (GRFS), a renowned name in the healthcare sector, stands out as a key player in the Drug Manufacturers – General industry. With its headquarters..

Labcorp Holdings Inc. (LH) Stock Analysis: Potential Upside with Strong Buy Ratings

Investors looking to delve into the healthcare sector should take note of Labcorp Holdings Inc. (NYSE: LH), a leading player in the Diagnostics & Research industry...

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Examining a 31% Potential Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a market capitalization of $10.06 billion. Headquartered in..

The Ensign Group, Inc. (ENSG) Stock Analysis: Evaluating a 11.43% Potential Upside

The Ensign Group, Inc. (ENSG), a key player in the healthcare sector, has recently captured the attention of investors with its impressive market cap of $11.49..

BioMarin Pharmaceutical Inc. (BMRN)

⚠️ No article content returned.

..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 10.84% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector, stands out in the medical instruments and supplies industry with a market capitalization..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 49.94% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is an intriguing player in the Healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $6.87 billion,..

Regencell Bioscience Holdings (RGC) Investor Outlook: A Unique Opportunity in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving a niche in the healthcare market through its innovative approach to Traditional Chinese Medicine (TCM). Headquartered in Causeway..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling 14.55% Potential Upside in the Booming Biotechnology Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology giant specializing in oncology, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With a robust..

The Cigna Group (CI) Stock Analysis: Unpacking a 12.67% Potential Upside

Investors seeking opportunities in the healthcare sector may find The Cigna Group (NYSE: CI) particularly compelling, given its robust market position and optimistic analyst outlook. With..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Examining the 16.39% Potential Upside for Savvy Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 14.42% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare industry, specifically within the healthcare plans segment. With a substantial market capitalization of..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 35.75% Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, currently offers a compelling investment opportunity with a noteworthy potential upside of 35.75%...

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a 2.17% Dividend Yield and High Analyst Confidence

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare industry, continues to capture investor attention with its robust market presence and diverse product offerings. With..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a key player in the animal health industry, with a market capitalization of $12.52 billion. As a prominent..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Growth Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) remains a formidable entity in the biopharmaceutical industry, with a rich history dating back to 1887. The company’s expansive portfolio spans..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring Its Robust Pipeline and Analyst Ratings

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a key player in the biotechnology sector, stands out for its pioneering RNA-targeted medicines. Headquartered in Carlsbad, California, Ionis is at..

Cencora, Inc. (COR) Stock Analysis: Unveiling a Promising 11.29% Potential Upside

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, is a titan in the healthcare sector, specializing in medical distribution. With a market capitalization of $69.89 billion,..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 12.68% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) is carving a niche in the highly competitive biotechnology industry, with a solid footprint in the healthcare sector. Headquartered in Minneapolis, Minnesota,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds